This review aims to summarise the evidence supporting the use of MFS as a clinical endpoint and the benefit of delaying metastasis in men with high-risk nmCRPC, and to discuss the influence of next-generation imaging on prostate cancer staging.
The Debate on Prostate Cancer Screening: What Does the Wisdom from the Old Books Whisper?
10 Mins
